A significant shift in Canadian drug policy has occurred, as the government announce the legalization of psilocybin mushrooms for therapeutic applications. Before this, these substances were strictly restricted, but a increasing body of research suggests they may offer relief for emotional illnesses like anxiety. This development represents a subst